Comparison of residents' pesticide exposure with predictions obtained using the UK regulatory exposure assessment approach  by Galea, Karen S. et al.
lable at ScienceDirect
Regulatory Toxicology and Pharmacology 73 (2015) 634e643Contents lists avaiRegulatory Toxicology and Pharmacology
journal homepage: www.elsevier .com/locate/yrtphComparison of residents' pesticide exposure with predictions obtained
using the UK regulatory exposure assessment approach
Karen S. Galea a, *, Laura MacCalman a, Kate Jones b, John Cocker b, Paul Teedon c,
John W. Cherrie a, d, Martie van Tongeren a
a Centre for Human Exposure Science, Institute of Occupational Medicine (IOM), Edinburgh, UK
b Health and Safety Laboratory (HSL), Buxton, UK
c School of Engineering and the Built Environment, Glasgow Caledonian University, Glasgow, UK
d School of Life Sciences, Heriot Watt University, Edinburgh, UKa r t i c l e i n f o
Article history:
Received 11 May 2015
Received in revised form
7 September 2015
Accepted 8 September 2015
Available online 11 September 2015
Keywords:
Regulatory exposure assessment
Pesticides
Urinary biomarkers
Agriculture
Biomonitoring
Residents* Corresponding author. IOM, Research Avenue N
EH14 4AP, UK.
E-mail address: karen.galea@iom-world.org (K.S. G
http://dx.doi.org/10.1016/j.yrtph.2015.09.012
0273-2300/© 2015 The Authors. Published by Elseviera b s t r a c t
The UK regulatory methods currently used for estimating residents' potential pesticide exposure were
assessed to determine whether they provide sufﬁciently conservative estimates. A non-random sample
of 149 residents living within 100 m of ﬁelds where pesticides were sprayed provided ﬁrst morning void
urine samples one and/or two days after spraying. Using farmers’ spray information, regulatory exposure
assessment (REA) models were applied to estimate potential pesticide intake among residents, with a
toxicokinetic (TK) model used to estimate urinary biomarker concentrations in the mornings of the two
days following the spray. These were compared with actual measured urinary biomarker concentrations
obtained following the spray applications. The study focused on ﬁve pesticides (cypermethrin, penco-
nazole, captan, chlorpyrifos and chlormequat). All measured cypermethrin urinary biomarker levels were
lower than the REA-predicted concentrations. Over 98% and 97% of the measured urinary biomarker
concentrations for penconazole and captan respectively were lower than the REA-predicted exposures.
Although a number of the chlorpyrifos and chlormequat spray-related urinary biomarker concentrations
were greater than the predictions, investigation of the background urinary biomarker concentrations
suggests these were not signiﬁcantly different from the levels expected had no pesticide spraying
occurred. The majority of measured concentrations being well below the REA-predicted concentrations
indicate that, in these cases, the REA is sufﬁciently conservative.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Government Ministers must approve all pesticides, including
those used in agriculture, horticulture, forestry, food storage and
the home or garden, before they can be marketed or used in Great
Britain. The regulatory health risk assessment underpinning the
approval of pesticides involves the comparison of estimates of
potential human exposure with toxicological reference levels; for
example, Acceptable Operator Exposure Level (AOEL) or Acceptable
Daily Intake (ADI), below which there is considered to be high
conﬁdence that there will be no adverse health effects.
The Chemicals Regulation Directorate (CRD) of the Britishorth, Riccarton, Edinburgh,
alea).
Inc. This is an open access article uHealth and Safety Executive (HSE) acts as the Regulator for pesti-
cide products and authorises their sale, supply, use and storage in
Great Britain. For residents, the exposure assessment submitted to
support approval must consider three scenarios; exposure at the
time of application (e.g. from spray drift), exposure after the
application (e.g. spray vapour) and exposure through entry into
areas where spray drift fallout has occurred (e.g. children's expo-
sure whilst playing in garden where drift has landed). Applicants
for pesticide approval may provide their own assessments based on
measurements made during application, other analogous mea-
surement data or exposure models to estimate exposure, provided
these produce an appropriate exposure assessment for each of
these exposure scenarios (HSE, 2012).
There is a general paucity of exposure measurements, in
particular for residents. Therefore the exposure assessment usually
relies on simple exposure assessment tools. Due to the inherent
nature of these tools, there is uncertainty associated with estimatesnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ability that will occur in individual exposures, the tools are
designed to provide conservative estimates; however, they have
not been comprehensively evaluated to determine if they are truly
conservative, in particular for residents. Work undertaken in pre-
vious studies of pesticide exposure suggests that the current REA
methods are sufﬁciently conservative for farm workers and pesti-
cide applicators (Cooper and Dobson, 2007; Sleeuwenhoek et al.,
2007; Colosio et al., 2011). However, there is a lack of information
on the potential exposures experienced by non-occupational
groups, such as bystanders and residents. Sleeuwenhoek et al.
(2007) reported that the REA model in use for Great Britain at the
time, may sometimes underestimate exposure for bystanders;
however, they did not collect data for residents.
The research project ‘Biological monitoring of pesticide expo-
sure in residents’ funded by the Department of Environment, Food
and Rural Affairs (DEFRA) aimed to assess whether the exposure
assessment tools used for the REA produce sufﬁciently conservative
estimates. Galea et al. (2015a) reported on residents' exposure to
captan, chlormequat, chlorpyrifos and cypermethrin in three
geographical areas of Great Britain, whilst a separate manuscript is
planned reporting on residents' exposure to penconazole.
In this manuscript, we compare the biomarker concentrations in
urine obtained from residents following spray events, with the
estimates obtained for residents using the exposure assessment
models applied in the pesticide approval process. These exposure
estimates were generated using spray event information provided
by participating farmers to estimate intake for our adult and child
participants residing within 100 m of the treated ﬁelds. The model
outputs were converted into estimated urinary biomarkers by
applying a toxicokinetic model, based on that of Rigas et al. (2001).
2. Materials and methods
2.1. Overview
The study received full ethical approval by the NHS South East
Scotland Research Ethics Committee (SESREC) 3 (study number 10/
S1103/63). Galea et al. (2011) describes the overall study design,
which is discussed in more detail in Galea et al. (2015b). In brief,
sample and data collection took place in three major arable crop
growing and orchard areas in Great Britain: East Lothian, Kent, and
Norfolk. Farmers were recruited into the study if they were likely to
spray their agricultural crops with relevant pesticides (captan,
chlormequat, chlorpyrifos, cypermethrin and penconazole) and
there were residential areas within 100 m of the ﬁelds being
sprayed. The farmers provided details of their pesticide usage
throughout the spray season. Residents (adults aged 18 years and
over and children in their care aged 4e12 years) livingwithin 100m
of the edge of a ﬁeld belonging to a recruited farmwere approached
to participate in the study. Participants provided informed written
consent. First morning void urine samples on one and/or two days
after a spray event were collected from participating residents, as
well as a number of ﬁrst morning void samples that were not
associated with spray events (background samples collected during
and outwith the spray season, with the spray season being taken to
be MarcheAugust). These urine samples were frozen as soon as
possible, being stored at 15 to 20 C prior to analysis.
Urine samples collected within 2 days of a relevant spraying
event were analysed only for the relevant pesticide(s) sprayed
during the event. Background samples, both within and outwith
the spray season, were analysed for all the relevant pesticides of
interest to the study. The analytical method for chlormequat was
based on that reported by Lindh et al. (2011) measuring chlorme-
quat itself. The analytical method for captan was based on thatreported by Berthet et al. (2011) measuring cis-1,2,3,6-
tetrahydrophthalimide (THPI). The analytical method for chlor-
pyrifos was based on that reported by Sams and Jones (2011)
measuring 3,5,6-trichlorpyridinol (TCP). The analytical method
for cypermethrin measured cis- and trans- 2,2-dichlorovinyl-3,3-
dimethylcyclopropane-1-carboxylic acid (DCVA) (Jones et al.,
2009). A novel method was developed during the study for pen-
conazole biomarkers and this was based on earlier work to develop
a method based on a major animal biomarker (Pen-COOH) (Jones
et al., 2009). More information on analytical methods is given in
Galea et al. (2015b).
The laboratory that analysed the urine samples participates in
external quality assurance schemes for chlorpyrifos and cyper-
methrin (G-EQUAS, www.g-equas.de). The analysts were blind to
whether the urine samples were related to spray events or were
background samples. All analytes were quantiﬁed using multi-
point matrix-matched calibration curves (including a blank) and
quality control samples (matrix spikes) were run every ﬁve samples
(coefﬁcient of variation <20% for all analytes). Samples were ana-
lysed in duplicate and the mean value reported. Aliquots of positive
samples were reanalysed throughout the project to evaluate sam-
ple stability. There was no evidence of sample degradation for any
biomarker studied throughout the assessment period.
2.2. Pesticides of interest and spray event information collected
Table 1 provides details of the pesticides considered in the
study, along with a summary of participants measured urinary
biomarker concentrations following the pesticide spray events.
These spray event related samples were obtained from 149 eligible
participants (125 adults and 24 children). Participants were
considered eligible if, after excluding samples with low (below
2 mmol/L) or high (greater than 30 mmol/L) creatinine concen-
trations (Cocker et al., 2011; EWDTS, 2002), they provided at least
one spray event related and at least one background urine sample.
Farmers were asked to provide details of their pesticide usage
throughout the spray season for the ﬁelds within 100 m of
participating households. This information included the start and
ﬁnish times of the spray event, product and active ingredients used,
quantities applied (weight of active substance/ha), dose rate, spray
method as well as the size of the ﬁeld, crop andweather conditions.
In instances where farmers already maintained comprehensive
records of their pesticide usage, the researcher requested copies of
these. Where detailed records were not already maintained,
participating farmers were asked to record the relevant informa-
tion using an adaptation of the spray record form recommended by
DEFRA (DEFRA, 2006).
2.3. Predicting residents’ exposures using regulatory exposure
assessment (REA) approach
Data for all spray events that involved products containing the
relevant pesticides and for which urine samples were collected
from participants were entered into a Microsoft Excel ﬁle in an
anonymous format. This ﬁlewas then forwarded to a representative
of the CRD who used this information to predict the residents’
exposures using the model applied in the regulatory process as
described below (HSE, 2012). These independent predictions were
made without any knowledge of the urinary biomarker concen-
trations obtained from the participants.
The REA models considered three pathways of exposure (HSE,
2012). The ﬁrst of these was direct exposure to spray drift at the
time of application. Based on values derived from generic ﬁeld
trials, estimates using the REA models were made of the amount of
pesticide that might be deposited on the skin and enter the
Table 1
Pesticides of interest and urinary biomarker levels (mg/g creatinine) following spray events (Galea et al. (2015b).
Pesticide Class Function LOD (mg/L) N % <LOD GM GSD Max 95% Ile
Captan Phthalimide Fungicide 0.1 255 91 a a 1.2 0.2
Cypermethrin Pyrethroid Insecticide 1.0 49 98 a a 7.0 5.8
Chlormequat Chlorocholine Growth regulator 0.6 197 2 15.4 2.7 248.1 72.4
Chlorpyrifos Organophosphate Insecticide 0.8 63 11 2.5 2.1 14.8 7.9
Penconazole Triazole Fungicide 0.25 89 81 a a 5.1 0.9
N ¼ number; LOD ¼ Limit of Detection; Max ¼ Maximum; GM ¼ Geometric Mean; GSD ¼ Geometric Standard Deviation; 95% ile ¼ 95th percentile.
a GM and GSD are not calculated due to the high proportion of values below LOD.
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estimates, the total systemic dose was calculated, using dermal
absorption data and information on inhaled air volumes. As the
generic ﬁeld data underlying the REA models are limited to mea-
surements on adults, estimates of direct exposure to spray drift
were made only for adults. The second pathway was inhalation of
pesticide vapour following volatilisation from plant or soil surfaces
after the application. In this case, estimates of potential daily
inhalation exposure were made using worst-case estimates of daily
concentrations of residues in air based on ﬁeld monitoring data.
The estimates of vapour exposure were made for both adults and
children, assuming they were continuously located next to the
treated crop. The third pathway was that of exposure via contact
with contaminated surfaces after application. This scenario was
conceptualised by considering the exposure of a young child
playing on a lawn in a garden next to a sprayed crop, where
pesticide spray had drifted onto the grass. Here, direct dermal
transfer and uptake following contact with pesticide residues on
turf along with oral exposure through hand-to-mouth transfer and
object-to-mouth transfer of pesticide residues were assessed. The
contributions of the different routes in each of these pathwayswere
summed to provide total estimates for each pathway. For each
spray event, the pathway providing the greatest predicted estimate
of exposure for the participant (adult or child) was used for com-
parison with the measured urinary biomarker concentrations.
When assessing proposed uses of pesticides, the REA considers
the worst-case recommended use (e.g. maximum recommended
dose applied) which is expected to give the highest exposures.
Actual uses are often lower, for example pesticides are often used at
a lower applied dose. Therefore, individual estimates were made in
this study reﬂecting details of the reported use for each of the
application events. Data on method of application, applied dose
and spray volume (litres of spray/ha) were used. In a small number
of cases spray volumes were not reported by the farmer. Using the
data obtained from the other participating farmers, missing spray
volumes for 38 broadcast air assisted applications were assigned a
value of 250 l/ha; this was the mode for the remaining 252 appli-
cations (arithmetic mean 279 L/ha). Four missing ground boom
spray volumes were assigned a value of 200 L/ha; the mode of the
51 similar applications (arithmetic mean 156 L/ha) by other
participating farmers. Dermal absorption values applied for the
individual products were taken from current regulatory assess-
ments (Table 2), with some of the data originating fromTable 2
Dermal absorption values used in regulatory exposure estimates.
Active substance Dermal absorption (%)
Captan 2
Chlormequat 4
Chlorpyrifos 1
Cypermethrin 10
lamda-cypermethrin 0.3
Zetacypermethrin 7
Penconazole 5unpublished studies submitted by applicants to support their
products (P. Hamey, personal communication).2.4. Toxicokinetic modelling
A simple toxicokinetic model (hereafter referred to as TKmodel)
was used to predict what the urinary biomarker concentration
would have been based on the estimated systemic dose from the
REA. The chosen model was used in a previous study of bystanders’
pesticide exposure (Sleeuwenhoek et al., 2007), based on that of
Rigas et al. (2001).
The model assumes that the pesticide is absorbed into a single
compartment within the body, as a single bolus dose, D. Equation
(1) describes how this dose of pesticide is then converted into the
level of biomarker of interest (Dm). The parameters used in this
equation are described in Table 3.
DM ¼
S$R
Vd
Mo
Mm
D (1)
where:
S ¼ selectivity ratio, amount on a molar basis of active ingre-
dient that can be collected as biomarker of interest
R ¼ stoichiometric ratio of the biomarker to active ingredient
M0 ¼ Molecular weight of active ingredient
Mm ¼ Molecular weight of biomarker
Vd ¼ Volume distribution, the apparent volume that accounts
for all of the active ingredient in the body.
The model then describes the transfer of this biomarker out of
the body and into the urine through two equations - one to describe
the concentration of the biomarker in the body [2], the other to
describe the concentration in the urine [3]. ke, the elimination rate,
is calculated from the half-life (HL) in hours.
dCB
dt
¼ keCB (2)
dCU
dt
¼ keCB (3)
where CB is the concentration in the body, with CB at t ¼ 0 being
DM, CU is the concentration in the urine and ke is the elimination
rate calculated from the half-life:
ke ¼ lnð2ÞHL (4)
The concentration in the urine at ﬁrst morning void was
calculated by subtracting the total amount accumulated in the
urine at the time of the last void in the evening before the urine
sample from the total amount accumulated in the urine at the time
of urine sample, and dividing by the total urinary volume over the
time since the last void. Urinary volume is assumed to accumulate
Table 3
Toxicokinetic (TK) modelling parameters.
Parameter Units Penconazole Captan Chlorpyrifos Cypermethrin Chlormequat
Biomarker 4-(2,4-Dichlorophenyl)
5-(H-1,2,4-triazol-1-yl)
pentoic acid
cis-1,2,3,6-tetrahydrophthalimide 3,5,6-trichlorpyridinol cis- and trans- 2,2-
Dichlorovinyl-3,3-
dimethylcyclopropane-
1-carboxylic acid
Chlormequat
M0 Molecular weight of
active ingredient
284.18 300.57 350.6 416.30 158.07
MM Molecular weight of
biomarker
314.2 151.17 198 208.06 158.07
S Selectivity Ratio 0.75e0.8 (female)a
0.45e0.6 (Male)a
0.0002 (dermal)b
0.035 (oral)b
0.013 (dermal)c
0.7 (oral)c
0.12 (dermal)d,e
0.36 (oral)d,e
Approx (1.0)f
R Stochiometric Ratio 0.8e1 0.8e1 0.8e1 0.8e1 0.8e1
Vd Volume Distribution L/kg 3e8 3e8 3e8 3e8 3e8
HL Half-life hours Approx 15a 13.4 (oral)b
21.3 (dermal)b
27 (oral)c
27 (dermal)c
16.5 (oral)d,e
13 (derma)d,e
Dual half-lifeg
2e3 h 10e14 h
Limit of detection mg/L 0.25 0.1 1 1 0.8
Comments on table.
 Data based on human volunteer studies, exception of penconazole (no human volunteer studies conducted at the time of modelling).
 Not every marker measured is a speciﬁc product of parent compound metabolism (TCPy, DCCA).
 Selectivity ratio - amount on a molar basis of the active ingredient that can be collected as biomarker of interest.
 Stochiometric ration eratio of active ingredient to its biomarker.
 Volume distribution (or the apparent volume that accounts for the entire active ingredient burden in the body); this is taken as 3e5 for children and 8 for adults.
 Oral half-lives and selectivity ratios were used for the TK modelling.
a ECHA (2012).
b Heredia-Ortiz and Bouchard (2012).
c Nolan et al. (1984).
d Woollen (1992).
e Eadsforth et al. (1988).
f As it is chlormequat it is measured in the urine.
g Lindh et al. (2011) e single volunteer study with two volunteers.
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In order to predict the urinary concentration, the dose (D, as
determined via the REA in mg/kg BW/day), was assumed to be
received as an instantaneous systemic exposure at four different
time points (8 am, 12 pm, 4 pm and 8 pm) on the day of spraying.
The different time points were used as it is not possible to know
exactly when exposure may have occurred following the spray
activity and were chosen to reﬂect both the typical earliest and
latest spray times reported by the participating farmers. The TK
model was run to predict the urinary biomarker concentration on
themorning of day 2 (up to 24-h) and day 3 (up to 48-h), where day
1 was assumed to be the day that the spray application took place.
Assumptions were made about the timing of the last urine void the
previous evening, these being between 8 pm and 12 am for adults,
and 6 pm and 9 pm for children, with a time chosen randomly for
each run of the model.
Table 3 outlines the information used by the model for each
pesticide and its associated biomarker. Oral half-lives and selec-
tivity ratios were used for the modelling as we assumed that oral,
rather than dermal or inhalation, was the predominant route but,
where available, the dermal parameters are given in the table for
completeness. Where a range was available for a given modelling
parameter (selectivity ratio, stoichiometric, time of last void, and
volume of distribution) a value was randomly generated from the
speciﬁed range. For the remaining parameters a value was
randomly chosen from a uniform distribution with limits þ-10% of
the point estimate in Table 3, with the exception of molecular
weights which are known constants. For each sample result the
Monte-Carlo model was run 10,000 times and an average REA-
based prediction was calculated.2.5. Statistical analysis
To determine if the exposure estimates from the REA were
conservative, we calculated the frequency that measured urinarypesticide biomarker concentrations exceeded the predicted
biomarker levels based on the REA. The comparisons were made
using the urinary concentrations not corrected for creatinine as
correcting the model predictions for creatinine would have
involved another set of assumptions. The measured urinary
biomarker levels are the result of pesticide exposure from the spray
event as well as any other sources of exposure (e.g. diet). In
contrast, the predicted urinary biomarker levels using the REA es-
timates only represent the potential exposure from the spray event.
Therefore, the predicted urinary levels based on the REA from the
spray were adjusted by adding the individual's average within-
season background levels of the urinary biomarker to the pre-
dicted urinary biomarker. So for individual j, sample i, background
corrected predicted urinary biomarker concentration (Qi,j) was
calculated by:
Qi;j ¼ Pi;j þ BGj (5)
where:
Pi,j¼ predicted urinary biomarker concentration for participant j
and spray event i
BGj ¼ average urinary biomarker concentration of all within-
season background samples for participant j
This was done for day 2 as well as day 3 urinary samples and for
the four initial assumed exposure times (8 am, 12 pm, 4 pm and
8pm).
Due to the short half-life of the pesticides, the predicted urinary
biomarker levels will reduce rapidly following a spray event. Hence,
the measured level may exceed predicted levels following a spray
event due to the variability in the background levels (i.e. if the
predicted level approaches 0 then the probability that background
levels will exceed the background adjusted predicted levels will
approach 50%). Therefore, we compared the frequency that the
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ground-corrected) predicted concentration following a spray event,
with the frequency that the measured background levels exceeded
the (background-adjusted) average REA predicted concentrations.
For each individual, the average REA-based prediction of their
associated spray events was calculated and corrected, as for the
predictions above, by adding the individual's averagewithin season
background urinary biomarker concentration, to obtain the back-
ground corrected average REA-based prediction for each individual
(Rj):
Rj ¼ Pj þ BGj (6)
where:
Rj ¼ average, background corrected, urinary biomarker con-
centration for all the relevant spray events for participant j
Pj ¼ average predicted urinary biomarker for participant j
BGj is the average within-season background level for partici-
pant j
The proportion of background urinary biomarker results above
this average background corrected REA-based prediction (%
BGij > Rj) was then compared to the proportion of the spray event
urinary biomarker results above the REA-based predictions (%
urinary biomarker result for spray event i and participant j > Qi,j) by
carrying out a binomial test of proportions.
The model was coded and run in Matlab (Mathworks); all sta-
tistical analysis was done using Genstat (VSN International, 2013)
and R (R Core Team) and all plots were generated using Sigmaplot
(Systat Software).
3. Results
3.1. Farms and relevant spray events
A total of 13 farms participated during 2011 and 17 during 2012
where pesticides containing at least one of the relevant active in-
gredients were applied. All participating Kent farms were orchards
whereas the remaining farms were all arable. Chlormequat and
cypermethrin were applied on farms in East Lothian and Norfolk
whereas captan, chlorpyrifos and penconazole were applied by the
Kent farms (Table 4). The number of spray days indicated was
derived by adding the number of days each pesticide was applied
on a ﬁeld within 100 m of the participants. It does not take into
account whether a urine sample was collected following these
events. It is clear that captan (a fungicide) containing products were
the most frequently applied of the ﬁve pesticides considered, and
cypermethrin the least.
3.2. Urine samples and data collection
A total of 149 residents (125 adults and 24 children) provided at
least one urine sample related to a relevant spray event. A total of
542 spray-event related samples were used in the REA comparisonsTable 4
Number of participating farms and spray days by pesticide and geographical area.
Area Farms (N) Spray days (n)
Captan Chlormequa
East Lothian 7 0 22
Kent 9 118 0
Norfolk 4 0 9
Total spray days 118 31with some samples being analysed for more than one pesticide,
resulting in 255 captan, 63 chlorpyrifos, 46 cypermethrin, 197
chlormequat and 89 penconazole spray-event related results.
3.3. REA estimates
Table 5 details for each pesticide, separately for adults and
children, the pathway that resulted in the highest REA exposure
estimate as well as the range of predicted exposures for this
pathway based on the spray event information provided by the
farmers. In addition, Table 5 provides details of the Acceptable
Operator Exposure Level (AOEL) for each of the pesticides.
For adults, in most instances, direct dermal contact and uptake
following contact with surfaces contaminated with pesticide res-
idue (e.g. due to spray drift) (pathway 3) resulted in the highest
exposure predictions, although for chlorpyrifos and penconazole,
volatisation of pesticides from the treated crop and surfaces was
also used (pathway 2). For chlorpyrifos the selection of either of
these pathways in the comparisons was dependent on the highest
exposure estimate generated for the particular spray event.
Pathway 2was used in all the child comparisons. It was evident that
the highest estimated pathway of exposure for each of the pesti-
cides was well below the AOEL.
Due to the high level of “non-detects” in the captan and
cypermethrin samples, only the numbers of samples above the
REA-based predicted exposure concentrations are reported. Table 6
reports the number and percentage of captan and cypermethrin
urinary biomarker results greater than the REA-based predicted
exposures, assuming exposure occurred at 8am for samples
collected up to one day (24 h) and two days (48 h) after the spray
event. The assumed time of exposure at 8 am is seen as the worst-
case in these analyses, the proportion of measured urinary
biomarker concentrations above the predicted decreases as
assumed time of exposure increases.
All measured 24 h urinary biomarker concentrations for captan
were below the exposure predicted to be present in the partici-
pants' urine using the REA-TK models. Eleven percent of the 48 h
urinary biomarker results were found to be above the predicted
urinary biomarker concentration. Four and seven cypermethrin
urinary biomarker results were above the level estimated in the
participants’ urine based on the REA-TK model predictions in 24
and 48 h samples, respectively. There was one penconazole
measured urinary biomarker result above the predicted exposure.
Where the measured urinary biomarker concentration was higher
than the background adjusted REA-TK predictions there was usu-
ally very little difference between the two values and both were
often below the LOD.
For chlorpyrifos, there were only 3 measured urinary biomarker
concentrations above the predicted exposures at 24 h, and 8 to 10
measured concentrations above the predicted exposures at 48 h
(depending on estimated timing that exposure occurred, see
Table 7). The majority of background corrected predictions were
higher than measured urinary biomarker levels in both 24 and 48 h
samples.
For chlormequat, there were 12e27 measured urinaryt Chlorpyrifos Cypermethrin Penconazole
0 2 0
27 0 33
0 1 0
27 3 33
Table 5
AOEL for each pesticide assessed and REA pathways resulting in the highest predicted exposure (and the range of estimates) based on farmers spray event information.
Pesticide AOEL (mg/kg BW) Adult Child
Pathway Predicted exposure (mg/kg BW) Pathway Predicted exposure (mg/kg BW)
Captan 100 3 8.0e24.0 2 8.30
Chlormequat 40 3 5.0e21.6 2 0.53
Chlorpyrifos 10 3
2
4.8
3.8
2 8.30
Cypermethrin 20 3 0.5e1.3 2 0.53
Penconazole 30 2 3.8 2 8.30
Pathway 2- inhalation following volatilisation of the pesticide after spray event; Pathway 3 e direct contact and uptake with surfaces contaminated with pesticide residue
after application; BW- body weight.
Table 6
Number and percentage of captan, cypermethrin and penconazole urinary biomarker results higher than the REA-TK-based predicted exposure, assuming exposure occurred at
8 am.
Pesticide Samples collected one day (up to 24-h) after spray event Samples collected two days (up to 48-h) after spray event
N Meas > pre (N) Meas > pre (%) N Meas > pre (N) Meas > pre (%)
Captana 94 0 0 147 11 8
Cypermethrin 22 4 18 24 7 21
Penconazole 27 0 0 55 1 2
a 25 samples were both 24 and 48 h samples due to spraying on two consecutive days.
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derived from the predicted REA-TK exposures at 24 h, and 33 to 39
measured urinary biomarker concentrations above the predicted
REA-TK biomarker concentrations at 48 h (Table 8). This equates to
around 40% of measured urinary biomarker concentrations in
excess of the predicted concentrations.
To understand whether the number of results higher than the
REA-TK based prediction differs from what would be expected, an
investigation of the background levels in relation to the predicted
levels was also undertaken.
Fig. 1 shows the measured urinary biomarker chlormequat
concentrations versus the background corrected REA-TK-based
prediction (PREDICTEDBCi,j). The points appear to be scattered
around the line of equality, at both 24 and 48 h indicating that,
while there are some measured levels higher than predicted, on
average they are equal. Looking at the plot of the within-season
background measurement (BGi,j) versus the mean of the REA-
based prediction (AM(REA)BCj) (Fig. 2), the pattern is similar. The
pattern is similar for chlorpyrifos (Figs. 3 and 4), although with
fewer measured being higher than background-corrected
predicted.
Table 9 shows that the percentage of spray-event related mea-
surements above background corrected predictions for chlorpyrifos
and chlormequat is not signiﬁcantly different from expected as the
p-value for the binomial test for difference is greater than 0.05,
with the exception of chlorpyrifos at 48 h. So although a number ofTable 7
Comparison of measured with predicted (based on REA-TK exposure predictions) biomar
ratio of the predicted to the measured.
Day after spray
N Meas > pre (N) GM (mg/l) G
Measured spray event biomarker conc. 2.5 2
Measured background biomarker conc. 3.0 2
Predicted exposure
8 am 20 3 3.4 1
12 pm 20 3 3.8 1
4 pm 20 3 4.2 1
8 pm 20 3 4.7 1
*Predicted statistically signiﬁcantly higher than measured; N ¼ number; GM ¼ Geometrthe chlorpyrifos and chlormequat spray event related urinary
biomarker concentrations were greater than the REA-TK-based
predictions these were generally not signiﬁcantly different to
what would be expected had no spray event occurred.
4. Discussion and conclusions
The main aim of this study was to assess whether the pesticide
exposure models used for the UK REA produce sufﬁciently con-
servative estimates for residents. To achieve this aim, there were a
number of issues that needed to be overcome such as obtaining
good quality spray information from participating farmers and the
timely collection of urine samples from participants coinciding
with relevant spray events. These difﬁculties were overcome
through the use of community researchers and successful
engagement with farmers and residents (Teedon et al., 2015).
The participating farmers, who volunteered to be involved, may
not have been representative of all farmers within the study areas
although there is no reason to suggest that their spraying practices
were different to those in the wider farming communities. The
farmers were enthusiastic and willing to share their spray records
and these were an essential component of the study and allowed
the exposure predictions to be generated using the REA tools. Spray
event start and ﬁnish times were obtained and residents were
asked to provide details of their activities in the 48-hr period prior
to provision of each urine sample. However, it was not possible toker levels for chlorpyrifos. The GM predicted levels are provided along with the GM
2 Days after spray
SD GM ratio N Meas > pre (N) GM (mg/l) GSD GM ratio
.4 2.6 2.2
.2 3.0 2.2
.3 0.4 35 10 2.0 1.4 0.5
.3 0.3 35 10 2.2 1.4 0.5
.3 0.3 35 10 2.4 1.4 0.5
.3 0.3 35 8 2.7 1.4 0.5
ic Mean; GSD ¼ Geometric Standard Deviation.
Table 8
Comparison of measured with predicted (based on REA-TK exposure predictions) for chlormequat. The GM predicted levels are provided along with the GM ratio of the
predicted to the measured.
Day after spray 2 Days after spray
N Meas > pre (N) GM (mg/l) GSD GM ratio N Meas > pre (N) GM (mg/l) GSD GM ratio
Measured spray event biomarker conc. 13.7 2.9 14.0 3.0
Measured background biomarker conc. 12.3 3.1 12.3 3.1
Predicted exposure
8 am 102 27 5.7 4.3 0.5 94 39 0.2 4.7 0.8
12 pm 102 20 9.9 4.3 0.4 94 37 0.4 4.7 0.8
4 pm 102 15 17.2 4.3 0.3 94 36 0.7 4.7 0.7
8 pm 102 12 29.3 4.3 0.2 94 33 1.3 4.7 0.7
Predicted statistically signiﬁcantly higher than measured; N ¼ number; GM ¼ Geometric Mean; GSD ¼ Geometric Standard Deviation.
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exposure to the assessed pesticides may have occurred, if at all. To
allow for the comparison with the REA predictions, a number ofFig. 1. Scatterplot of measured urinary biomarker chlormequat concentrations against
the background corrected REA-based urinary predictions. This is at 24 h (left) and 48 h
(right). The symbols distinguish between adults and children.
Fig. 2. Scatterplot of measured urinary biomarker within-season background chlor-
mequat concentrations against the arithmetic mean background corrected REA-TK-
based urinary biomarker predictions (AM-REA). The symbols distinguish between
adults and children.time periods (start of exposure and provision of urine sample) were
considered to accommodate this lack of information.
The TK model used, based on that of Rigas et al. (2001), is a
simple one-compartment model which described the excretion of
biomarkers in the urine, over time, given an internal dose of
pesticide. There are a number of mathematical models that could
be used to predict the urinary pesticide output, ranging from the
simple single compartment model, which treats the body as a
kinetically homogenous unit, with plasma or serum as the
anatomical reference compartment (Lu et al., 2010; Lu and Andres,
2011; Rigas et al., 2001) to more complex physiologically-based
pharmacokinetic (PBPK) models, which make use of physiological
and biochemical information to quantify pharmacokinetic pro-
cesses inﬂuencing distribution and disposition of chemicals within
an organism (Goldsmith et al., 2012; Wen et al., 1999; Lu et al.,
2010). Use of a more comprehensive PBPK model would allow
estimation of the distribution of biomarker(s) around all organs of
the body, and excretion, over time but there is very little infor-
mation available for the required parameters meaning that a
number of assumptions would have to be made and, consequently,
there would be a high level of uncertainty around any estimates.
The values of the parameters used for the TK modelling were
obtained from published literature where information such as
Fig. 3. Scatterplot of measured urinary biomarker chlorpyrifos concentrations against
the background corrected REA-based urinary predictions. This is at 24 h (left) and 48 h
(right). The symbols distinguish between adults and children.
Fig. 4. Scatterplot of measured urinary biomarker within-season background chlor-
pyrifos concentrations against the arithmetic mean background corrected REA-TK-
based urinary biomarker predictions (AM-REA). The symbols distinguish between
adults and children.
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studies. In order to evaluate how the model predictions would be
affected by the value of these parameter estimates, we undertook aTable 9
Comparison of measured spray and background urinary biomarker concentrations with
chlormequat.
Day after spray
N Meas > pre (N) Meas > pre (%) P-valu
Chlorpyrifos
Spray 20 3 15
Within 145 11 8 0.265
Chlormequat
Spray 102 27 26
Within 330 62 19 0.094simple sensitivity analysis. Using chlormequat as an example, it
was found that doubling the half-life effectively doubled the 24 h
prediction and resulted in an increase in the 48 h prediction by a
factor of 9. Similarly, doubling the selectivity ratio doubled the
prediction at both 24 and 48 h. The volume of distribution had an
inverse relationship with the 24 and 48 h predictions, where
doubling the volume of distribution effectively halved the pre-
dicted values. Therefore, most of the parameters were observed to
have a multiplicative effect on the prediction, with the exception of
half-life, which could potentially have a big impact on the predic-
tion, particularly at 48 h. The predictions made by this model are
sensitive to the estimates of the model parameters, which is to be
expected. The model parameters used were all obtained from
published literature and, while there is uncertainty about their
accuracy, we can assume that the point estimates are relatively
close to reality. The uncertainty in the parameter estimates has
been dealt with, to some extent, by simulating values from distri-
butions rather than using point estimates.
When considering proposed uses of pesticides, the REA process
considers the worst-case directions for use which are expected to
produce the highest exposures. However, in reality pesticides are
often used at lower doses. In our comparisons, the predicted
exposure concentrations were made reﬂecting the reported use
details for each of the application events as provided by the farmers
therefore providing a more accurate assessment of potentialpredicted (based on REA-TK exposure predictions) exposure for chlorpyrifos and
Two days after spray event
e N Meas > pre (N) Meas > pre (%) P-value
35 10 29
145 20 14 0.035
94 39 41
330 127 38 0.599
K.S. Galea et al. / Regulatory Toxicology and Pharmacology 73 (2015) 634e643642exposure. Although the regulatory exposure assessment process
allows for the separate assessment of three pathways of exposure,
only the pathway providing the highest predicted exposure is then
used. For our adult participants this was typically the direct contact
and uptake pathways (3) following contact with contaminated
surfaces whereas for the child participants this was exposure
following evaporation of the pesticide following application
(pathway 2) for the spray applications reported and considered in
this study. It should be considered that the measured biomarker
concentrations from the collected urine samples reﬂect pesticide
exposures frommultiple pathways of exposure, not just those used
in the comparisons, and also includes exposure via other sources
such as diet.
The REA process necessarily considers each pesticide in isola-
tion. There is some public concern but limited data about the effects
of pesticide mixtures. In this study farmers’ spray records showed
that for the majority of spray events, the relevant pesticides were
applied with other pesticide products. For captan and penconazole,
there were a number of occasions where these products were both
applied using the same tank mixture. No relationship between
penconazole and captan biomarker concentrations, in instances
where both were sprayed at the same time, was found.
Due to the high proportion of measured urinary biomarker
concentrations for captan, cypermethrin and penconazole being
non-detects, only the number and percentage of samples above the
predicted exposures are reported. For cypermethrin the measured
urinary biomarker levels were all found to be lower than the pre-
dicted concentrations. Over 98% of themeasured urinary biomarker
concentrations for penconazole and 97% of measured captan uri-
nary biomarker concentrations were found to be lower than the
predicted exposures. The majority of measured concentrations
were well below the REA-based predicted concentrations indi-
cating that for these cases the REA is sufﬁciently conservative.
A greater number of measured urinary biomarker results were
above the analytical limit of detection for chlorpyrifos and chlor-
mequat. Initial comparisons of the measured urinary biomarker
concentrations with the predicted exposures found that 20% of
chlorpyrifos and 40% of chlormequat urinary biomarker concen-
trations were greater than those derived from the predicted con-
centrations. As no statistically signiﬁcant differences in pesticide
biomarker concentrations following spray events were found
compared to background urinary biomarker concentrations for
these pesticides (Galea et al, 2015b) we compared the background
urinary biomarker concentrations with those derived from the
predicted exposures to further understand these results. Overall,
the proportion of measured urinary biomarker concentrations in
excess of the modelled concentrations for the relevant spray events
were no different to what would be expected if no spray event had
taken place. In conclusion, the results from this paper suggest that
the contribution from spraying of the reported ﬁve pesticides to
agricultural ﬁelds to the overall pesticide exposure of UK residents
is low (under the conditions observed in this study) and that the
REA method used to predict residential exposure to these pesti-
cides appears to be sufﬁciently conservative.
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